✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Avian Influenza Vaccine Market Research Report Information, by Strain (H5, H7, H9), Application (Chicken, Turkey, Goose & Duck) and Region (APAC & Middle East, Europe, Americas, Africa) - Forecast till 2032


ID: MRFR/HC/7297-CR | 101 Pages | Author: Rahul Gotadki| February 2020
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 LIST OF ASSUMPTIONS 14

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 16

3.2 DATA MINING 16

3.3 SECONDARY RESEARCH 17

3.4 PRIMARY RESEARCH 17

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20

3.6.1 BOTTOM-UP APPROACH 21

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 INCREASING STRATEGIC AGREEMENTS 25

4.2.2 INCREASING PUBLIC AND PRIVATE INITIATIVES FOR RESEARCH AND DEVELOPMENT 25

4.3 RESTRAINTS 26

4.3.1 UNAFFORDABILITY OF PROVIDING VETERINARY SERVICES IN UNDEVELOPED AND DEVELOPING ECONOMIES 26

4.4 OPPORTUNITIES 27

4.4.1 INCREASING NUMBER OF CLINICAL TRIAL CANDIDATES 27

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS 28

5.1.1 R&D & DESIGNING 29

5.1.2 MANUFACTURING 29

5.1.3 DISTRIBUTION, MARKETING, AND SALES 29

5.2 PORTER’S FIVE FORCES MODEL 30

5.2.1 THREAT OF NEW ENTRANTS 30

5.2.2 BARGAINING POWER OF SUPPLIERS 31

5.2.3 BARGAINING POWER OF BUYERS 31

5.2.4 THREAT OF SUBSTITUTES 31

5.2.5 INTENSITY OF RIVALRY 31

6 AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

6.1 OVERVIEW 32

6.2 H5 33

6.3 H7 34

6.4 H9 34

7 AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

7.1 OVERVIEW 35

7.2 CHICKEN 36

7.3 TURKEY 37

7.4 GOOSE & DUCK 37

8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION

8.1 OVERVIEW 39

8.2 APAC & MIDDLE EAST 41

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.1 CHINA 43

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.2 PHILIPPINES 44

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.3 VIETNAM 44

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.4 INDIA 45

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.5 BANGLADESH 46

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.6 CAMBODIA 46

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.7 INDONESIA 47

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.8 IRAN 48

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.9 THAILAND 48

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.10 PAKISTAN 49

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.2.11 REST OF APAC & MIDDLE EAST 50

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3 EUROPE 51

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.1 GERMANY 53

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.2 BULGARIA 53

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.3 POLAND 54

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.4 HUNGARY 55

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.5 UKRAINE 55

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.6 CZECH REPUBLIC 56

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.3.7 REST OF EUROPE 57

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4 AMERICAS 58

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.1 US 60

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.2 BRAZIL 60

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.3 MEXICO 61

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.4 ARGENTINA 62

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.5 COLUMBIA 62

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.4.6 REST OF THE AMERICAS 63

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5 AFRICA 64

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5.1 SOUTH AFRICA 65

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5.2 NIGERIA 66

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5.3 GHANA 67

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5.4 CAMEROON 67

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

8.5.5 REST OF AFRICA 68

AVIAN INFLUENZA VACCINE MARKET, BY STRAIN

AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 69

9.2 COMPETITIVE ANALYSIS 69

10 COMPANY PROFILES

10.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 70

10.1.1 COMPANY OVERVIEW 70

10.1.2 FINANCIAL OVERVIEW 71

10.1.3 PRODUCTS/SERVICES OFFERED 71

10.1.4 KEY DEVELOPMENTS 72

10.2 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD 73

10.2.1 COMPANY OVERVIEW 73

10.2.2 FINANCIAL OVERVIEW 73

10.2.3 PRODUCTS/SERVICES OFFERED 73

10.2.4 KEY DEVELOPMENTS 73

10.3 CEVA 74

10.3.1 COMPANY OVERVIEW 74

10.3.2 FINANCIAL OVERVIEW 74

10.3.3 PRODUCTS/SERVICES OFFERED 75

10.3.4 KEY DEVELOPMENTS 75

10.4 YEBIO BIOENGINEERING CO., LTD 76

10.4.1 COMPANY OVERVIEW 76

10.4.2 FINANCIAL OVERVIEW 76

10.4.3 PRODUCTS/SERVICES OFFERED 76

10.4.4 KEY DEVELOPMENTS 76

10.5 ZOETIS 77

10.5.1 COMPANY OVERVIEW 77

10.5.2 FINANCIAL OVERVIEW 77

10.5.3 PRODUCTS/SERVICES OFFERED 78

10.5.4 KEY DEVELOPMENTS 78

10.6 FATRO S.P.A. 79

10.6.1 COMPANY OVERVIEW 79

10.6.2 FINANCIAL OVERVIEW 79

10.6.3 PRODUCTS/SERVICES OFFERED 79

10.6.4 KEY DEVELOPMENTS 79

10.7 CAVAC 80

10.7.1 COMPANY OVERVIEW 80

10.7.2 FINANCIAL OVERVIEW 80

10.7.3 PRODUCTS/SERVICES OFFERED 80

10.7.4 KEY DEVELOPMENTS 80

10.8 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD 81

10.8.1 COMPANY OVERVIEW 81

10.8.2 FINANCIAL OVERVIEW 81

10.8.3 PRODUCTS/SERVICES OFFERED 81

10.8.4 KEY DEVELOPMENTS 81

10.9 PT JAPFA COMFEED INDONESIA TBK 82

10.9.1 COMPANY OVERVIEW 82

10.9.2 FINANCIAL OVERVIEW 82

10.9.3 PRODUCTS/SERVICES OFFERED 83

10.9.4 KEY DEVELOPMENTS 83

10.10 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD 84

10.10.1 COMPANY OVERVIEW 84

10.10.2 FINANCIAL OVERVIEW 84

10.10.3 PRODUCTS/SERVICES OFFERED 84

10.10.4 KEY DEVELOPMENTS 84

10.11 MERCK ANIMAL HEALTH 85

10.11.1 COMPANY OVERVIEW 85

10.11.2 FINANCIAL OVERVIEW 85

10.11.3 PRODUCTS/SERVICES OFFERED 86

10.11.4 KEY DEVELOPMENTS 86

10.12 MEDION 87

10.12.1 COMPANY OVERVIEW 87

10.12.2 FINANCIAL OVERVIEW 87

10.12.3 PRODUCTS/SERVICES OFFERED 87

10.12.4 KEY DEVELOPMENTS 87

10.13 AVIMEX ANIMAL HEALTH 88

10.13.1 COMPANY OVERVIEW 88

10.13.2 FINANCIAL OVERVIEW 88

10.13.3 PRODUCTS/SERVICES OFFERED 88

10.13.4 KEY DEVELOPMENTS 88

10.14 JOVAC 89

10.14.1 COMPANY OVERVIEW 89

10.14.2 FINANCIAL OVERVIEW 89

10.14.3 PRODUCTS/SERVICES OFFERED 89

10.14.4 KEY DEVELOPMENTS 89

10.15 QYH BIOTECH COMPANY LIMITED 90

10.15.1 COMPANY OVERVIEW 90

10.15.2 FINANCIAL OVERVIEW 90

10.15.3 PRODUCTS/SERVICES OFFERED 90

10.15.4 KEY DEVELOPMENTS 90

11 APPENDIX

11.1 REFERENCES 91

11.2 RELATED REPORTS 91

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 14

TABLE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 32

TABLE 3 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H5, BY REGION, 2023–2032 (USD MILLION) 33

TABLE 4 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H7, BY REGION, 2023–2032 (USD MILLION) 34

TABLE 5 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H9, BY REGION, 2023–2032 (USD MILLION) 34

TABLE 6 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 35

TABLE 7 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR CHICKEN, BY REGION, 2023–2032 (USD MILLION) 36

TABLE 8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR TURKEY, BY REGION, 2023–2032 (USD MILLION) 37

TABLE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR GOOSE, BY REGION, 2023–2032 (USD MILLION) 38

TABLE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR DUCK, BY REGION, 2023–2032 (USD MILLION) 38

TABLE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2023–2032 (USD MILLION) 39

TABLE 12 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 42

TABLE 13 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 42

TABLE 14 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 43

TABLE 15 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 43

TABLE 16 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 43

TABLE 17 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 44

TABLE 18 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 44

TABLE 19 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 44

TABLE 20 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 45

TABLE 21 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 45

TABLE 22 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 45

TABLE 23 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 46

TABLE 24 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 46

TABLE 25 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 46

TABLE 26 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 47

TABLE 27 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 47

TABLE 28 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 47

TABLE 29 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 48

TABLE 30 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 48

TABLE 31 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 48

TABLE 32 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 49

TABLE 33 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 49

TABLE 34 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 49

TABLE 35 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 50

TABLE 36 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 50

TABLE 37 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 52

TABLE 38 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 52

TABLE 39 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 52

TABLE 40 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 53

TABLE 41 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 53

TABLE 42 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 53

TABLE 43 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 54

TABLE 44 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 54

TABLE 45 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 54

TABLE 46 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 55

TABLE 47 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 55

TABLE 48 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 55

TABLE 49 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 56

TABLE 50 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 56

TABLE 51 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 56

TABLE 52 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 57

TABLE 53 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 57

TABLE 54 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 59

TABLE 55 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 59

TABLE 56 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 59

TABLE 57 US: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 60

TABLE 58 US: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 60

TABLE 59 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 60

TABLE 60 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 61

TABLE 61 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 61

TABLE 62 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 61

TABLE 63 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 62

TABLE 64 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 62

TABLE 65 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 62

TABLE 66 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 63

TABLE 67 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 63

TABLE 68 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 63

TABLE 69 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 64

TABLE 70 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 65

TABLE 71 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 65

TABLE 72 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 65

TABLE 73 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 66

TABLE 74 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 66

TABLE 75 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 66

TABLE 76 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 67

TABLE 77 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 67

TABLE 78 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 67

TABLE 79 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 68

TABLE 80 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023–2032 (USD MILLION) 68

TABLE 81 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023–2032 (USD MILLION) 68

TABLE 82 MAJOR MANUFACTURERS: GLOBAL AVIAN INFLUENZA VACCINE MARKET 69

TABLE 83 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 71

TABLE 84 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 72

TABLE 85 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 73

TABLE 86 CEVA: PRODUCTS/SERVICES OFFERED 75

TABLE 87 CEVA: KEY DEVELOPMENTS 75

TABLE 88 YEBIO BIOENGINEERING CO., LTD: PRODUCTS/SERVICES OFFERED 76

TABLE 89 ZOETIS: PRODUCTS/SERVICES OFFERED 78

TABLE 90 ZOETIS: KEY DEVELOPMENTS 78

TABLE 91 FATRO S.P.A.: PRODUCTS/SERVICES OFFERED 79

TABLE 92 CAVAC: PRODUCTS/SERVICES OFFERED 80

TABLE 93 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 81

TABLE 94 PT JAPFA COMFEED INDONESIA TBK: PRODUCTS/SERVICES OFFERED 83

TABLE 95 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD: PRODUCTS/SERVICES OFFERED 84

TABLE 96 MERCK ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 86

TABLE 97 MERCK ANIMAL HEALTH: KEY DEVELOPMENTS 86

TABLE 98 MEDION: PRODUCTS/SERVICES OFFERED 87

TABLE 99 AVIMEX ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 88

TABLE 100 JOVAC: PRODUCTS/SERVICES OFFERED 89

TABLE 101 QYH BIOTECH COMPANY LIMITED: PRODUCTS/SERVICES OFFERED 90

13 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET STRUCTURE 15

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL AVIAN INFLUENZA VACCINE MARKET 24

FIGURE 5 DRIVER IMPACT ANALYSIS 26

FIGURE 6 RESTRAINT IMPACT ANALYSIS 26

FIGURE 7 SUPPLY CHAIN ANALYSIS 28

FIGURE 8 PORTER’S FIVE FORCES MODEL 30

FIGURE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023 (%) 32

FIGURE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2023 & 2032 (USD MILLION) 33

FIGURE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023 (%) 35

FIGURE 12 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 36

FIGURE 13 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2023 (%) 39

FIGURE 14 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2023 & 2032 (USD MILLION) 40

FIGURE 15 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023 (%) 41

FIGURE 16 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023 (%) 51

FIGURE 17 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023 (%) 58

FIGURE 18 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2023 (%) 64

FIGURE 19 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 71

FIGURE 20 CEVA: FINANCIAL OVERVIEW SNAPSHOT 74

FIGURE 21 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT 77

FIGURE 22 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 81

FIGURE 23 PT JAPFA COMFEED INDONESIA TBK: FINANCIAL OVERVIEW SNAPSHOT 82

FIGURE 24 MERCK ANIMAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 85

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Press Release
Category icon
Avian Influenza Vaccine Market Outlook and Opportunities in Grooming Regions with Forecast 2025
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)